federal_register: 2020-21023

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2020-21023 Cannabidiol and Other Cannabinoids: Sex and Gender Differences in Use and Responses; Public Meeting Notice The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses." The purpose of the public meeting is to discuss potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids. Researchers, educators, clinicians, and patients may benefit from attending this multidisciplinary scientific conference on CBD and other cannabinoids. Presentations will address patient and healthcare provider perspectives on CBD and other cannabinoid use, sex differences in the effects of CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research and evaluation. 2020-09-23 2020 9 https://www.federalregister.gov/documents/2020/09/23/2020-21023/cannabidiol-and-other-cannabinoids-sex-and-gender-differences-in-use-and-responses-public-meeting https://www.govinfo.gov/content/pkg/FR-2020-09-23/pdf/2020-21023.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses." The purpose of the public meeting is to discuss potential sex...  

Links from other tables